Polymerase I and Transcript Release Factor (PTRF) Peptide
PTRF
Reactivity: Human
Host: Synthetic
BP, WB, IHC
-
- Target See all PTRF products
- PTRF (Polymerase I and Transcript Release Factor (PTRF))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-PTRF antibody (Catalog #: ARP36965_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- PTRF (Polymerase I and Transcript Release Factor (PTRF))
- Background
-
In mouse, pausing of elongation complexes is mediated by the transcription termination factor TTF-I bound to the 'Sal box' terminator downstream of the rDNA transcription unit. PTRF is a Pol I and transcript release factor for dissociation of paused ternary complexes.
Alias Symbols: Cavin, Cav-p60, AW546441, 2310075E07Rik
Protein Size: 392 - Molecular Weight
- 43 kDa
- Gene ID
- 19285
- NCBI Accession
- NM_008986, NP_033012
- UniProt
- O54724
-
You are here:
